Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation

被引：14
作者：
Restelli, Valentina [1 ]
Vagni, Micaela [1 ]
Arribas, Alberto J. [2 ]
Bertoni, Francesco [2 ,3 ]
Damia, Giovanna [1 ]
Carrassa, Laura [1 ]
机构：
[1] IRCCS, Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Mol Pharmacol, Milan, Italy
[2] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland
[3] IOSI Oncol Inst Southern Switzerland, Bellinzona, Switzerland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 01期
关键词：
diffuse large B cell lymphoma; CHK1; WEE1; MYC; combined targeted therapy; PHASE; COMBINATION; CANCER;
D O I：
10.1111/bjh.14506
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：129 / 133
页数：5
相关论文
共 10 条
  • [1] Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
    Barrans, Sharon
    Crouch, Simon
    Smith, Alex
    Turner, Kathryn
    Owen, Roger
    Patmore, Russell
    Roman, Eve
    Jack, Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3360 - 3365
  • [2] Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase
    Buisson, Remi
    Boisvert, Jessica L.
    Benes, Cyril H.
    Zou, Lee
    [J]. MOLECULAR CELL, 2015, 59 (06) : 1011 - 1024
  • [3] Combined inhibition of Chk1 and Wee1 In vitro synergistic effect translates to tumor growth inhibition in vivo
    Carrassa, Laura
    Chila, Rosaria
    Lupi, Monica
    Ricci, Francesca
    Celenza, Cinzia
    Mazzoletti, Marco
    Broggini, Massimo
    Damia, Giovanna
    [J]. CELL CYCLE, 2012, 11 (13) : 2507 - 2517
  • [4] Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
    Chila, Rosaria
    Basana, Alessandra
    Lupi, Monica
    Guffanti, Federica
    Gaudio, Eugenio
    Rinaldi, Andrea
    Cascione, Luciano
    Restelli, Valentina
    Tarantelli, Chiara
    Bertoni, Francesco
    Damia, Giovanna
    Carrassa, Laura
    [J]. ONCOTARGET, 2015, 6 (05) : 3394 - 3408
  • [5] Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
    Daud, Adil I.
    Ashworth, Michelle T.
    Strosberg, Jonathan
    Goldman, Jonathan W.
    Mendelson, David
    Springett, Gregory
    Venook, Alan P.
    Loechner, Sabine
    Rosen, Lee S.
    Shanahan, Frances
    Parry, David
    Shumway, Stuart
    Grabowsky, Jennifer A.
    Freshwater, Tomoko
    Sorge, Christopher
    Kang, Soonmo Peter
    Isaacs, Randi
    Munster, Pamela N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) : 1060 - +
  • [6] Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
    Hoeglund, Andreas
    Nilsson, Lisa M.
    Muralidharan, Somsundar Veppil
    Hasvold, Lisa A.
    Merta, Philip
    Rudelius, Martina
    Nikolova, Viktoriya
    Keller, Ulrich
    Nilsson, Jonas A.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (22) : 7067 - 7079
  • [7] Stromal Gene Signatures in Large-B-Cell Lymphomas
    Lenz, G.
    Wright, G.
    Dave, S. S.
    Xiao, W.
    Powell, J.
    Zhao, H.
    Xu, W.
    Tan, B.
    Goldschmidt, N.
    Iqbal, J.
    Vose, J.
    Bast, M.
    Fu, K.
    Weisenburger, D. D.
    Greiner, T. C.
    Armitage, J. O.
    Kyle, A.
    May, L.
    Gascoyne, R. D.
    Connors, J. M.
    Troen, G.
    Holte, H.
    Kvaloy, S.
    Dierickx, D.
    Verhoef, G.
    Delabie, J.
    Smeland, E. B.
    Jares, P.
    Martinez, A.
    Lopez-Guillermo, A.
    Montserrat, E.
    Campo, E.
    Braziel, R. M.
    Miller, T. P.
    Rimsza, L. M.
    Cook, J. R.
    Pohlman, B.
    Sweetenham, J.
    Tubbs, R. R.
    Fisher, R. I.
    Hartmann, E.
    Rosenwald, A.
    Ott, G.
    Muller-Hermelink, H. -K
    Wrench, D.
    Lister, T. A.
    Jaffe, E. S.
    Wilson, W. H.
    Chan, W. C.
    Staudt, L. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (22) : 2313 - 2323
  • [8] Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma
    Ravi, Dashnamoorthy
    Beheshti, Afshin
    Abermil, Nassera
    Passero, Frank
    Sharma, Jaya
    Coyle, Michael
    Kritharis, Athena
    Kandela, Irawati
    Hlatky, Lynn
    Sitkovsky, Michail V.
    Mazar, Andrew
    Gartenhaus, Ronald B.
    Evens, Andrew M.
    [J]. CANCER RESEARCH, 2016, 76 (11) : 3319 - 3331
  • [9] Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer
    Scagliotti, Giorgio
    Kang, Jin Hyoung
    Smith, David
    Rosenberg, Richard
    Park, Keunchil
    Kim, Sang-We
    Su, Wu-Chou
    Boyd, Thomas E.
    Richards, Donald A.
    Novello, Silvia
    Hynes, Scott M.
    Myrand, Scott P.
    Lin, Ji
    Smyth, Emily Nash
    Wijayawardana, Sameera
    Lin, Aimee Bence
    Pinder-Schenck, Mary
    [J]. INVESTIGATIONAL NEW DRUGS, 2016, 34 (05) : 625 - 635
  • [10] Genetic lesions in diffuse large B-cell lymphomas
    Testoni, M.
    Zucca, E.
    Young, K. H.
    Bertoni, F.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (06) : 1069 - 1080
1